Walgreens Boots Alliance has agreed to pay $100 million to settle a class action lawsuit alleging deceptive pricing practices within its Prescription Savings Club program. The plaintiffs claimed Walgreens inflated prices for generic drugs to insurers while offering lower prices to cash-paying customers, resulting in overpayments for insured individuals. The settlement comes as Walgreens faces scrutiny over its pricing practices and its impact on healthcare costs.